BLOG

empowered

Platform for Meaningful Delivery of Cancer Vaccines for Multiple Tumor Types with Andrew Hall IMV

Andrew Hall is the CEO of IMV Inc, which has developed a platform based on a lipid-in-oil technology that encapsulates the therapeutic. When injected subcutaneously, the drug remains in a specific location to reinvigorate the immune system to overcome the tumor surveillance that allows cancer to grow.